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Activation of Endothelial Transient Receptor Potential C3 Channel
Is Required for Small Conductance Calcium-Activated Potassium
Channel Activation and Sustained Endothelial Hyperpolarization
and Vasodilation of Cerebral Artery
Mikhail Y. Kochukov, PhD, MD; Adithya Balasubramanian, MS; Joel Abramowitz, PhD; Lutz Birnbaumer, PhD; Sean P. Marrelli, PhD
Background-—Transient receptor potential C3 (TRPC3) has been demonstrated to be involved in the regulation of vascular tone
through endothelial cell (EC) hyperpolarization and endothelium-dependent hyperpolarization–mediated vasodilation. However, the
mechanism by which TRPC3 regulates these processes remains unresolved. We tested the hypothesis that endothelial receptor
stimulation triggers rapid TRPC3 trafficking to the plasma membrane, where it provides the source of Ca2+ influx for small
conductance calcium-activated K+ (SKCa) channel activation and sustained EC hyperpolarization.
Methods and Results-—Pressurized artery studies were performed with isolated mouse posterior cerebral artery. Treatment with a
selective TRPC3 blocker (Pyr3) produced significant attenuation of endothelium-dependent hyperpolarization–mediated
vasodilation and endothelial Ca2+ response (EC-specific Ca2+ biosensor) to intraluminal ATP. Pyr3 treatment also resulted in a
reduced ATP-stimulated global Ca2+ and Ca2+ influx in primary cultures of cerebral endothelial cells. Patch-clamp studies with
freshly isolated cerebral ECs demonstrated 2 components of EC hyperpolarization and K+ current activation in response to ATP.
The early phase was dependent on intermediate conductance calcium-activated K+ channel activation, whereas the later sustained
phase relied on SKCa channel activation. The SKCa channel–dependent phase was completely blocked with TRPC3 channel
inhibition or in ECs of TRPC3 knockout mice and correlated with increased trafficking of TRPC3 (but not SKCa channel) to the
plasma membrane.
Conclusions-—We propose that TRPC3 dynamically regulates SKCa channel activation through receptor-dependent trafficking
to the plasma membrane, where it provides the source of Ca2+ influx for sustained SKCa channel activation, EC hyperpolarization,
and endothelium-dependent hyperpolarization–mediated vasodilation. ( J Am Heart Assoc. 2014;3:e000913 doi: 10.1161/
JAHA.114.000913)
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T ransient receptor potential (TRP) nonselective cationchannels are widely expressed in different tissues and
contribute to cytosolic Ca2+ signaling in response to mechan-
ical, thermal, and chemical stimulation.1,2 Several members of
the TRP channel family expressed in vascular endothelium
play an important role in arterial tone and blood flow
regulation.3–6 One important mechanism of such regulation
involves small and intermediate conductance calcium-
activated K+ (SKCa and IKCa, respectively) channels, which
may be activated by Ca2+ influx through TRP channels at the
endothelial plasma membrane (PM).6–9
Endothelial SKCa and IKCa channels play a pivotal role in
regulating arterial tone by hyperpolarizing endothelial cells
(ECs) in response to increased cytosolic Ca2+. This hyperpo-
larization is then transferred to surrounding smooth muscle
cells via intercellular gap-junctions, thus providing smooth
muscle cell relaxation. This described process of vasodilation
is referred to as endothelium-dependent hyperpolarization
(EDH).10–14 Pharmacological activators or blockers of SKCa
and IKCa channels can affect resting or active tone in isolated
arteries,10,11,13,15 as well as in situ blood flow.13,16,17
TRPC3, a member of the “canonical” subfamily of TRP
channels, has been implicated in endothelium-mediated
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regulation of arterial tone; however, its regulation and exact
role in the EDH-mediated dilations are not well understood.
The mode of channel activation by intracellular lipid messen-
gers such as diacylglycerol suggests a functional link between
TRPC3 and the G protein–coupled receptor/phospholipase C
(PLC) signaling cascade, activated by hormones and paracrine
factors.18,19 Two recent studies have suggested that endo-
thelial TRPC3 contributes to the vasorelaxation response to
luminal flow and bradykinin.20,21 In addition, we recently
presented evidence for a significant role of TRPC3 in EDH-
mediated dilation through SK/IKCa channel–mediated EC
hyperpolarization in mesenteric artery.8 This latter study
provided the first evidence linking TRPC3 channel activation
and SK/IKCa channel activation in vascular endothelium.
In the present study, we sought to determine the temporal
role of TRPC3 in the regulation of SKCa and IKCa channels in
vascular endothelium of cerebral artery. From our findings,
we now propose a new model in which TRPC3 channels
dynamically regulate SKCa channel activation through recep-
tor-dependent trafficking of TRPC3 to the PM (see Figure 12,
later). This regulation of TRPC3 thus contributes to a complex
time course of K+ channel activation comprising the overall




All animal experiments were performed in accordance with
Baylor College of Medicine Institutional Animal Care and Use
Committee guidelines (September 1, 2011, revision). Gener-
ation of TRPC3 knockout (KO) mice has been described
previously.22 Cx40BAC-GCaMP2 transgenic mice, expressing
calcium biosensor GCaMP2 selectively in ECs,23 were
obtained from the Cornell Center for Technology Enterprise
and Commercialization. P2Y2 KO mice
24 were obtained
through Jackson Laboratory (stock 009132). All experiments
were performed with male mice.
Pressurized Artery Studies
The posterior cerebral artery (PCA) was dissected from the
brain and placed in a perfusion chamber (ChuelTech). The
artery was cannulated with 2 micropipettes and secured with
ties consisting of individual strands of a polyester thread.
Warmed (37°C) and gassed (21% O2–5% CO2, balance N2)
Krebs buffer was used for abluminal and luminal perfusion of
the artery. Luminal flow (30 to 50 lL/min) was established by
setting the luminal inflow and outflow reservoirs at a slight
height differential. Arteries were monitored for changes in
diameter by using video-microscopy. L-NAME (10 lmol/L)
and indomethacin (10 lmol/L) were administered to inhibit
nitric oxide synthase and cyclooxygenase, respectively. In
these conditions, arteries developed spontaneous myogenic
tone. In all experiments, ATP (and, in some instances, A23187
at 10 lmol/L) were administered through the lumen of the
artery via a miniature remotely operated manifold system to
achieve rapid delivery of agents despite very low flow rates.
Vasodilation evoked by ATP was calculated as a difference in
peak vessel diameter (time averaged over 50 seconds) before
and after ATP and normalized to maximal artery diameter (in
Ca2+-free, 3 mmol/L EGTA solution).
EC Ca2+ Measurement in Pressurized Artery
For endothelial Ca2+ measurement within pressurized arteries,
the PCA from Cx40BAC-GCaMP2 mice was prepared as
described earlier. Ca2+ measurements were performed in
the presence of L-NAME and indomethacin at 10 lmol/L
each. The vessel chamber was placed on the stage of an
inverted TE200 fluorescence microscope equipped with a
Nikon Super Fluor 10X objective (Nikon Instruments). Photo-
metric measurement of endothelial Ca2+ was performed with
a customized UV/photometry system (C&L Instruments),
which we have previously used for fura-2–based measure-
ments.3,25–29 The UV excitation passed through a heat filter,
variable aperture, and band pass excitation filter (475/20;
Chroma Technology) before being directed into the micro-
scope via a liquid light guide. The emission signal was
transmitted through a dichroic mirror and then a second liquid
light guide to the photometer equipped with an emission band
pass filter (520/40; Chroma Technology). UV lamp output was
attenuated approximately 50% to reduce cell damage. Sam-
pling was performed at 20 Hz, and a 5-second running
average transform was applied for final analysis (SigmaPlot).
Ca2+ signal in ECs was detected as an increase in
GCaMP2 fluorescence in response to intraluminal application
of ATP. The signal was then normalized to the “maximal” Ca2+
response to ionophore A23187 (10 lmol/L). Specificity of
the GCaMP2 signal to the endothelium was confirmed by
endothelial denudation by air.30 Removal of the endothelium
resulted in complete absence of fluorescence change to ATP
and A23187. Possible artifact due to artery dilation and
constriction was additionally ruled out by using PCA isolated
from Tie2-GFP mice (Ca2+-insensitive EC-specific GFP expres-
sion) that were run through the same diameter range.
Mouse PCA TRPC3 Immunofluorescence Staining
PCA were removed from both Cx40BAC-GCaMP2::TRPC3 WT
and Cx40BAC-GCaMP2::TRPC3 KO mice and mounted in a
pressurized vessel chamber dedicated for fixation studies (see
Figure 10A, later). Additionally, cerebral arteries were
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removed from WT (C57BL/6) mice and treated as just
described (see Figure 10C and 10D, later). Each vessel was
pressurized as described earlier and perfused luminally and
abluminally with solution containing (in mmol/L): 140 NaCl,
5.6 KCl, 1.6 CaCl2, 1 MgCl2, 10 glucose, and 10 HEPES, pH
7.3. In certain instances, the luminal solution additionally
contained 100 lmol/L ATP to activate the endothelium. The
artery was fixed while pressurized (60 mm Hg) in the chamber
with a 10% formalin solution for 10 minutes. At the end of
fixation, the artery was cut open along the axis of flow to
permit complete access to the endothelial surface for antibody
and later imaging. The vessel was then transferred to a bullet
tube to perform the permeabilization with 0.2% Triton X for
15 minutes. The vessels were exposed to the blocking solution
(10% goat serum, 0.5% BSA, 0.1% Tween-20 in PBS) for
4 hours at room temperature on a rocker. Tissues were
subsequently incubated overnight in rabbit polyclonal anti-
TRPC3 primary antibody (ab75171; Abcam) at 1:200 dilution in
block solution. After PBS washes, the arteries were probed for
1 hour with Alexa Fluor 594 goat anti-rabbit IgG antibody
(Invitrogen) at 1:500 dilution. Arteries were then arranged on
glass slides in DAPI-containing mounting media (Vector Labs)
for fluorescence microscopy (Olympus IX81 with SlideBook
4.2).
EC isolation and Recording Conditions
For Ca2+ imaging experiments, ECs were obtained from
mouse PCA and middle cerebral artery (MCA) explants grown
on BD Matrigel Basement Membrane Matrix (BD Biosciences)
as described by Suh et al31 with slight modifications. Briefly,
35-mm culture dishes were coated with BD Matrigel and
diluted 1:1 with DMEM containing glucose and L-glutamine
(Gibco) for 1 to 2 hours at room temperature. Cerebral
arteries were carefully excised from brain surface, cleaned of
meningeal membranes, washed in Hank’s buffer, minced into
2-mm pieces, and transferred to Matrigel-coated dishes
containing DMEM supplemented with 10% FBS (Gibco),
100 lg/mL endothelial cell growth supplement (BD Bio-
sciences), 10 U/mL heparin (Sigma), 100 U/mL penicillin/
streptomycin (Invitrogen), and 2% minimal essential amino
acid mixture (Sigma). Vessel pieces attached to the gel
surface and were grown for 4 to 12 weeks (37°C and 5% CO2)
to allow ECs to proliferate and spread throughout the
Matrigel. Purity of the resulting cells was confirmed in
preliminary experiments by using Tie2-GFP transgenic mice.
For experiments, ECs were harvested from the gel matrix by
using 1-hour incubation with neutral protease (4 mg/mL;
Worthington Biochemical) in PBS, washed twice with DMEM,
and plated onto Petri dishes or 12-mm glass cover-slips
coated with fibronectin (BD Biosciences) 50 lg/mL for
2 hours.
Freshly dispersed ECs used in electrophysiological exper-
iments were obtained from the PCA and MCA through
enzymatic dissociation (70 minutes at 37°C) by using neutral
protease (4 U/mL) and elastase (1 U/mL) in the following
digestion buffer (in mmol/L): 138 NaCl, 5 KCl, 1.5 MgCl2,
0.42 Na2HPO4, 0.44 NaH2PO4, 0.1 CaCl2, 10 HEPES, 4.2
NaHCO3, and 0.3% BSA. The digestion was completed with a
2-minute incubation with collagenase type 1 (120 U/mL) in
the same digestion buffer. All enzymes were obtained from
Worthington. After washing, partially digested vessels were
triturated using a 200-lL pipette tip. The resulting EC
suspension was placed on ice and typically used at 2 to
6 hours after digestion.
Experiments were performed in an RC-25 chamber (Warner
Instruments). Extracellular bath solution contained (in mmol/
L) 140 NaCl, 5.6 KCl, 1.6 CaCl2, 1 MgCl2, 10 glucose, and 10
HEPES, pH 7.3. The pipette solution for electrophysiological
recordings contained (in mmol/L) 40 KCl, 100 K gluconate, 1
MgCl2, 10 NaCl, 0.1 EGTA, 10 NaCl, 10 HEPES, and 0.1 EGTA,
pH 7.2. Pharmacological agents dissolved in bath saline were
applied to the cells either via gravity flow or through the large-
bore pipette to the chamber for more rapid solution exchange.
EC Ca2+ Imaging
At the time of experimentation, ECs were loaded with fura-
2AM (TefLabs) for 1 hour at 2.5 lmol/L and imaged by
acquiring 340/380-nm fluorescence ratios (R340/380) every
4 seconds, with an Olympus IX81 fluorescent microscope
equipped with a Uplan S-Apo 209 0.75 NA lens (Olympus),
Lambda LS Xenon Arc lamp, Lambda 10-2 filter wheel shutter
controller (both from Sutter Instruments), and RET-EXi-F-M-
12-C CCD-camera (QImaging) and controlled with Slidebook
4.2 Imaging software (Olympus). Background fluorescence
was determined from a region without cells and was
subtracted before ratio determination. R340/380 time-lapse
data acquired from individual cells were baseline subtracted
and expressed as an agonist-induced DR340/380. In Mn2+-
quenching experiments,32 cells were additionally excited at
360 nm (D360/10x-25 filter; Chroma Technology), the isos-
bestic point for fura-2, and the resulting 510-nm fluorescent
images were acquired at 3.6-second intervals.
Patch-Clamp Electrophysiology
EC membrane currents or voltage were recorded from EC
clusters, typically consisting of 3 to 12 cells, with calculated
membrane capacitance ranging from 4 to 30 pF. Recordings
were done in either voltage- or current-clamp modes by using
the perforated patch configuration of whole-cell recording
with use of a Multiclamp 700B patch-clamp amplifier,
DigiData 1440A computer interface, and Clampex 10.0
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acquisition and analysis software (Molecular Devices). The
bath was grounded with an Ag-AgCl pellet via a bridge of
1 mol/L KCl in 2% agarose. Amphotericin B (0.8 mg/mL) was
added to the pipette solution immediately before the record-
ing. The series resistance was maintained at or below 30 MO
and was not compensated. For voltage-clamp recordings, ECs
were held at 70 mV, and whole-cell currents were evoked
by 1.5-second voltage ramps from 120 to +60 mV every
3 seconds. Potassium currents activated by ATP or NS-309
were analyzed after subtraction of baseline current, recorded
before the agonist application. For membrane capacitance
(Cm) measurements, EC Cm was monitored by using the time
domain technique33 in which 10-mV test pulses were applied
from a 70-mV holding potential in whole-cell mode. Data
were acquired by using the membrane test feature in
ClampEx.
Statistics
SigmaPlot 11.0 (Systat Software) was used for statistical
analyses. All data are expressed as meanSEM. For pressur-
ized artery studies, n represents the number of animals from
which arteries were taken. Calcium imaging recordings from
individual cells were averaged for each coverslip (12 to 59
cells per coverslip) representing a minimum of 3 mice for each
group. For electrophysiological experiments, individual record-
ings from EC clusters were combined to calculate an averaged
recording. Comparisons between TRPC3 KO and wild-type
(WT) data sets contained samples from at least 3 mice for
each group. The average responses were evaluated by using
2-way repeated-measures ANOVA with the Holm–Sidak test
for pairwise multiple comparison procedures. Whole artery EC
Ca2+ measurements were evaluated as the area under the
curve and compared by using t test. Vasodilation responses
were compared by using 2-way repeated-measures ANOVA
with the Holm–Sidak test for individual comparisons. A value
of P<0.05 was considered significant.
Results
Cerebral Artery Endothelial TRPC3 Contributes to
ATP-Mediated Vasodilation Through Endothelial
Ca2+ Regulation
Although TRPC3 has been shown to be involved in endothe-
lium-mediated vasodilation/vasorelaxation in peripheral arter-
ies,8,20,21 a role for this channel in vasodilation has never
been reported for cerebral arteries. Thus, to determine the
role of TRPC3 in endothelium-mediated vasodilation of
cerebral artery, we performed experiments in pressurized
PCA treated with either vehicle or Pyr3 (1 lmol/L), a blocker
of TRPC3. ATP (10 and 100 lmol/L) was delivered through
the lumen of the arteries to promote endothelium-dependent


























































Figure 1. TRPC3 contributes to EDH-mediated vasodilation in cerebral artery. A, Representative EDH-
mediated dilation responses to ATP (10 to 100 lmol/L) in PCA. L-NAME and indomethacin were included
to isolate the EDH component of vasodilation. Arteries were treated with either vehicle (0.01% DMSO,
control) or 1 lmol/L Pyr3 before ATP delivery. Arteries were bathed in Ca2+-free solution (no Ca2+ and
3 mmol/L EGTA) to obtain maximal relaxation at the end of the experiment (indicated by horizontal bar).
B, Average EDH-mediated dilation to ATP in vehicle or Pyr3 pretreated PCA. Data are presented as a percent
of maximal dilation in Ca2+-free conditions. *P<0.05; 2-way repeated-measures ANOVA. EDH indicates
endothelium-dependent hyperpolarization; PCA, posterior cerebral artery; TRPC3, transient receptor
potential C3.
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with L-NAME and indomethacin to isolate the EDH-mediated
component of vasodilation.34 Spontaneous myogenic tone
was similar for control and Pyr3-treated arteries. Application
of Pyr3 produced 256% tone compared with 213%
in control arteries (P=0.53); maximum diameters for each
group were 1902 (control) and 1883 lm (Pyr3-treated).
Figure 1A shows representative PCA diameter measurements
in response to cumulative ATP delivery. Note that ATP
(100 lmol/L) produced sustained and near-maximal dilations
in control arteries, whereas it produced oscillatory and
submaximal dilations in Pyr3-treated arteries. The dilation
responses are summarized in Figure 1B as a percentage of
maximal diameter (Ca2+-free conditions). Note that EDH-
mediated dilation was significantly attenuated in Pyr3-treated
arteries (P=0.024; 2-way repeated-measures ANOVA).
Once a role for TRPC3 in EDH-mediated dilation was
demonstrated in the cerebral circulation, we next sought
to determine the specific role of this channel in EC Ca2+
regulation and subsequent EC hyperpolarization. We hypoth-
esized that TRPC3 provides the source of Ca2+ influx
necessary to sustain EC hyperpolarization after receptor
stimulation. To evaluate this possibility, we measured ATP-
mediated changes in endothelial Ca2+ in intact pressurized
PCA from mice expressing a fluorescent Ca2+ biosensor
selectively in the endothelium (Cx40BAC-GCaMP2).23,35,36
Because the present study reflects the first reported
application of this method in cerebral arteries, we performed
a series of validation experiments. In one study, we removed
the endothelium with a bolus of air to determine the cell-
specificity of the fluorescent response and rule out possible
fluorescence artifact from ATP and A23187. Note that the
change in fluorescence to ATP was abolished after endothelial
denudation (Figure 2A, bottom trace). Similarly, there was no
change in fluorescence to A23187 (not shown). In a separate
study, we additionally confirmed that fluorescence change
was not due to change in artery diameter. In this separate
experiment, we exposed an endothelial GFP-expressing artery
(Tie2-GFP), in which the fluorescent signal is not Ca2+
dependent, to the full range of artery diameters by changing
intraluminal pressure. There was no diameter-dependent
effect on fluorescence in these studies (not shown).
Once validated, we used the GCaMP2 biosensor method to
determine the EC Ca2+ response to luminal ATP in control and
Pyr3-treated PCA. As shown in Figure 2A, ATP produced an
increase in endothelial Ca2+ within intact pressurized arteries.
The maximal response was approximately 20% of the full
response elicited by luminal A23187 (10 lmol/L). In the
presence of Pyr3, however, the Ca2+ response to ATP was
significantly attenuated. The summary of ATP responses
(normalized to the A23187 response) is shown in Figure 2B
and demonstrates significant attenuation after TRPC3 inhibi-







































Figure 2. Role of TRPC3 in ATP-mediated endothelial Ca2+ response in pressurized PCA. A, Represen-
tative recordings of endothelial Ca2+ response to ATP in isolated PCA from Cx40BAC-GCaMP2 mice.
Measurements were performed following incubation with vehicle (0.01% DMSO) or Pyr3 (1 lmol/L). ATP
was additionally delivered to an artery in which the endothelium was removed by luminal air bubble (endo
denuded). Data are shown as a change in GCaMP2 fluorescence after baseline subtraction and correction
for photobleaching. B, Summary of endothelial Ca2+ responses to ATP in control (n=4) and Pyr3-pretreated
PCA (n=4), shown as an average increase in GCaMP2 fluorescence normalized to maximal signal in the
presence of A23187 ionophore. The arrow indicates the point where ATP reached the artery lumen. The
endothelial Ca2+ responses were compared as the AUC of individual recordings from control and Pyr3-
pretreated PCA. *P<0.05 t test comparing group AUC. AUC indicates area under the curve; PCA, posterior
cerebral artery; TRPC3, transient receptor potential C3.
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Cerebral EC TRPC3 Contributes to Ca2+ Influx in
Response to ATP
In a preliminary set of experiments, we recorded Ca2+
responses to ATP in fura-2–loaded ECs freshly isolated from
PCA and MCA (not shown) and found it problematic for
quantitative studies due to considerable cell movement and
background artifacts. As a more suitable tool, we used
primary cultures of cerebral artery ECs. As shown in
Figure 3A, ATP produced a transient (0.5 to 6 minutes)
increase in endothelial Ca2+. The Ca2+ responses recorded
from individual cells ranged from oscillatory to single
prolonged peaks. The response was completely abolished by
preincubation with PLC inhibitor U73122 (4 lmol/L),
demonstrating critical dependence on a P2Y receptor/PLC–
activated cascade rather than direct P2X-mediated Ca2+
influx. Coapplication of a Ca2+ chelator (4 mmol/L BAPTA)
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Figure 3. Ca2+ response to ATP in primary cerebral EC cultures. A through C, Ca2+ response as an average
change in fura-2 340/380-nm ratio per coverslip. A, EC Ca2+ response to 1, 10, and 100 lmol/L ATP (n=6,
13, and 16, respectively) and 100 lmol/L ATP after 20 minutes’ pretreatment with PLC inhibitor U73122 at
4 lmol/L (n=2). B, EC Ca2+ response to 100 lmol/L ATP in bath solution Ca2+-containing buffer
(1.6 mmol/L Ca2+) or Ca2+-free buffer (nominally Ca2+-free plus 4 mmol/L BAPTA; n=6). For the Ca2+-free
experiments, buffer was switched from Ca2+-containing to Ca2+-free at the time of ATP application to avoid
depletion of internal Ca2+ stores. The average Ca2+ response to ATP in 1.6 mmol/L Ca2+ saline is shown for
comparison (n=10). C, Summary of EC Ca2+ responses to 100 lmol/L ATP with and without a TRPC3
inhibitor (Pyr3, 1 lmol/L) in ECs from WT (upper panel) and TRPC3 KO (lower panel) mice. Number of
coverslips is each group is shown in parentheses. D, The effect of Pyr 3 (1 lmol/L) on ATP (100 lmol/L)-
stimulated Mn2+ influx in ECs, as detected by quenching of fura-2 fluorescence at 360 nm (F360). Summary
data are shown as normalized fluorescence changes per cell (n=33 and 3 in control and Pyr3-treated ECs,
respectively). Inset graph shows the summary of fluorescence changes as the first derivative (dF/dt). The
arrow indicates the point of ATP application. Note that the rapid initial drop in F360 is due to partial overlap
with the prominent F380 signal that decreases on ATP-stimulated Ca2+ increase. The lower subpanel shows
average Mn2+-independent changes in F360 (n=25), recorded in Mn2+-free bath saline. KO indicates
knockout; PLC, phospholipase C; TRPC3, transient receptor potential C3; WT, wild type.
DOI: 10.1161/JAHA.114.000913 Journal of the American Heart Association 6















 at NIH Library on November 10, 2014http://jaha.ahajournals.org/Downloaded from 
confirming a significant role for Ca2+ influx in the ATP-stim-
ulated response (Figure 3B). Further, the TRPC3 blocker Pyr3
(1 lmol/L) suppressed the Ca2+ response to ATP in duration,
similar to the effect of Ca2+ chelation with BAPTA (Figure 3C,
top). ECs cultured from TRPC3 KO mice (bottom panel) also
demonstrated a more transient Ca2+ response to ATP
compared with the described WT response. Application of
Pyr3 to the ECs from TRPC3 KO mice did not produce a
further reduction in the Ca2+ response, demonstrating the
specificity of Pyr3 in the component of the Ca2+ response
typically associated with Ca2+ influx.
While these data demonstrated a prominent role of
membrane TRPC3 in ATP-mediated Ca2+ regulation in cerebral
ECs, a direct demonstration of this channel in Ca2+ influx was
still needed. To specifically evaluate Ca2+ influx, we used the
fura-2/Mn2+–quenching technique.3,32 Addition of 1 mmol/L
Mn2+ to the bath solution resulted in some baseline
quenching (compare with bottom graph, where Mn2+ was
not added) (Figure 3D). This reflection of basal Ca2+ influx did
not differ between control and Pyr3-treated cells. Application
of ATP produced a considerable increase in quenching over
baseline, indicating activation of Ca2+/Mn2+-permeable PM
channels. The rate of quenching (dF360/dt) is presented in the
inset. The rate of quenching was significantly reduced in ECs
treated with Pyr3, thus demonstrating the involvement of
TRPC3 in ATP-mediated Ca2+ influx.
SKCa and IKCa Channels Play Distinct Roles in
ATP-Mediated Cerebral EC Hyperpolarization
We examined the roles of SKCa and IKCa channels in
ATP-mediated EC hyperpolarization by patch-clamp
measurements of freshly isolated clusters of ECs from
mouse PCA and MCA. EC membrane potential was mea-
sured by current-clamp and whole-cell K+ currents by voltage
clamp in amphotericin B–perforated cells. The isolated
clusters of ECs selected for patch-clamp recording had
electrical capacitance in a range of 6 to 30 pF, depending on
the number of cells in the cluster. We avoided clusters of
greater cell number due to limitations of voltage-clamping
clusters of a larger capacitance. Two types of baseline
current in unstimulated EC clusters were revealed. The
majority of ECs showed little outward current and a Kir-like
inward current that was sensitive to Ba2+ (100 lmol/L) or a
specific Kir2.x blocker ML133 (10 lmol/L)
37 at negative
voltage (Figure 4A). The reversal potential in resting condi-
tions ranged from 20 to 0 mV, which correlated well with
membrane voltage measured from unstimulated cells in the
current-clamp mode. Interestingly, about 20% of cells
showed very little inward current and a prominent delayed
rectifier-type outward current at positive voltage (Figure 4B).
A similar current was recently described in microvascular
ECs from rat brain and attributed to Kv1 family voltage-
dependent K+ channel(s).38 We found that cells of this type
did not show any increase in current or change of reversal
potential in response to ATP or direct SKCa/IKCa channel
activator NS309 (not shown). Note that all remaining studies
with ATP are exclusively performed with the more prevalent
Kir-expressing population of ECs.
Because both P2Y1 and P2Y2 purinergic receptors can
mediate endothelium-mediated vasodilation in cerebral
arteries,28,39,40 we tested the receptor specificity of ATP-
mediated SKCa/IKCa current activation by using ECs isolated
from WT and P2Y2 KO mice. Note that the ATP-stimulated




Figure 4. Representative current-voltage (I-V) recordings of baseline whole-cell currents in freshly
isolated clusters of cerebral ECs. Whole-cell I-V recordings were performed with freshly isolated cerebral
ECs. Cell voltage was ramped from 120 to +60 mV (0.18 V/s) from a holding potential of 70 mV.
A, Representative recording from an EC displaying a “Kir-dependent current.” Baseline I-V response with no
treatment (cont) and with a Kir 2.x channel blocker, BaCl2 (100 lmol/L). The Ba
2+-sensitive current is
shown in the inset. Similar results were obtained with Kir 2.x channel blocker, ML133 (10 lmol/L).
B, Representative recording of an EC displaying a “Kv-like current.”
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K+ current was virtually abolished in ECs from P2Y2 KO mice
(Figure 5). To ensure that the functional expression of
SKCa/IKCa channels was not altered in P2Y2 KO animals,
ECs were treated at the end of each experiment with a
direct activator of SKCa/IKCa channels (NS309 10 lmol/L).
Application of NS309 produced a robust current increase
that was not significantly different between groups, thus
demonstrating an equivalent capacity for SK/IKCa-mediated
current activation (data not shown). These data demonstrate
that ATP signals primarily through P2Y2 receptors in this
preparation.
Figure 6A shows a representative hyperpolarization
response to ATP, recorded from an EC cluster of 3 cells.
About half of recorded clusters, like the one shown, revealed
spontaneous negative voltage spikes lasting for a few seconds
each. Application of ATP resulted in a profound (to 40 to
60 mV) and long-lasting (about 10 minutes) hyperpolariza-
tion. Figure 6B summarizes the distinct temporal roles of
SKCa and IKCa channels in ATP-mediated EC hyperpolarization.
In preliminary experiments, we demonstrated that ATP-
mediated EC hyperpolarization was essentially completely
dependent on combined SKCa/IKCa channel activation (not
shown). Therefore, we were able to isolate the role of IKCa
channel activation by inhibiting SKCa channels (and vice
versa). TRAM34 treatment (IKCa blocker) primarily attenuated
the peak hyperpolarization response, with little attenuation of
the ensuing sustained component. In contrast, UCL1684
treatment (SKCa blocker) had no effect on the peak hyperpo-
larization response but completely eliminated the sustained
component.
The whole-cell currents responsible for ATP-mediated EC
hyperpolarization were further evaluated by briefly switching
between current-clamp and voltage-clamp modes to obtain
current-voltage plots at each condition (Figure 6C). The ATP-
stimulated current was partially attenuated by IKCa blockade
(TRAM34 10 lmol/L) and completely abolished by combined
SKCa and IKCa blockade (UCL1684 0.2 lmol/L and TRAM34).
The temporal contribution of SKCa and IKCa channel activation
to ATP-stimulated whole-cell current at +40 mV is summa-
rized in Figure 6D. Note that inhibition of SKCa channels with
apamin (200 nmol/L) dramatically attenuated the sustained
component (similar results obtained with UCL1684). The
current-voltage plots specifically corresponding to IKCa and
SKCa channel activation were generated by calculating the
TRAM34- and UCL1684-sensitive currents, respectively (Fig-
ure 6E). Note the characteristically greater inward rectifica-
tion at positive voltages for the IKCa current-voltage
relationship compared with that of SKCa.
41 The summary of
the normalized current-voltage relationships corresponding
to SKCa (black) and IKCa (gray) are depicted in the inset.
Figure 6F demonstrates the shift in the whole-cell current-
voltage relationship of total K+ current without blockers
during the course of ATP stimulation. The inset figure is a
representative experiment depicting the time points of the
response at which current-voltage relationships were evalu-
ated—at the end of the peak response (denoted as 1) and
during the sustained component (denoted as 2). Summary of
current-voltage relationships obtained at the end of the peak
response (summary plot 1) strongly resemble IKCa-dependent
relationships, whereas current-voltage relationships obtained
during the sustained component (summary plot 2) strongly
resemble SKCa-dependent relationships. From these aggre-
gate data, it appears that ATP produces EC hyperpolarization
through a combination of IKCa and SKCa channel activation,
where IKCa channels contribute to the initial hyperpolarization
and SKCa channels contribute to the sustained hyperpolar-
ization.
TRPC3 Contributes to SKCa Channel Activation
and ATP-Mediated Cerebral EC Hyperpolarization
Having demonstrated a role of TRPC3 in EC Ca2+ influx and
EDH-mediated vasodilation, we next sought to determine the
functional link between TRPC3 activation and EC hyperpolar-
ization. Given that ATP-mediated EC hyperpolarization is
entirely dependent on SKCa/IKCa channel activation, we
specifically evaluated the potential of TRPC3 in regulating









Figure 5. Requirement of P2Y2 receptor in ATP-mediated
current activation in freshly isolated cerebral ECs. ATP
(100 lmol/L)-activated current was recorded during ramps
(120 to +60 mV) in voltage-clamp mode and is presented as
the outward current at +40 mV measured over time. Responses
are summarized for ECs isolated from WT (C57Bl/6; n=5) and
P2Y2 receptor KO mice (n=7). Current was normalized to cell
capacitance and presented as mean current density (pA/pF).
All data presented as meanSEM. Group difference=P<0.01;
2-way repeated-measures ANOVA. KO indicates knockout;
WT, wild type.
DOI: 10.1161/JAHA.114.000913 Journal of the American Heart Association 8















 at NIH Library on November 10, 2014http://jaha.ahajournals.org/Downloaded from 
The role of TRPC3 in ATP-mediated EC hyperpolarization
was determined by pharmacological inhibition with Pyr3
(1 lmol/L) and in cells isolated from TRPC3 KO mice
(Figure 7). Pharmacological inhibition of TRPC3 demon-
strated no attenuation of peak hyperpolarization (Figure 7A)
or the initial outward current (Figure 7B), whereas the
respective sustained components were abolished. Genetic
deletion of TRPC3 similarly had no effect on the peak
hyperpolarization response (Figure 7C). The sustained
































































Figure 6. Biphasic contribution of SKCa and IKCa channels in ATP-mediated hyperpolarization of freshly
isolated cerebral ECs. A, Representative current-clamp measurement of ATP-induced hyperpolarization in
freshly isolated cerebral artery ECs. B, Summary of ATP-mediated hyperpolarization in the absence of
blockers (cont; n=7) and in the presence of SKCa blocker (UCL1684; n=3) and IKCa blocker (TRAM34; n=6).
C, Representative I-V recordings at baseline and then after sequential application of ATP, TRAM34, and
combined UCL1684/TRAM34. ATP was present throughout all recordings after the baseline measurement.
D, Summary of whole-cell current measured at +40 mV in response to ATP application. Current was
measured from sequential I-V sweeps following no treatment (control; n=9), SKCa inhibition (apamin, 200
nmol/L; n=4), and combined SKCa/IKCa inhibition (apamin+TRAM34, 1 lmol/L; n=3). E, Representative
normalized SKCa (black) and IKCa I-V response (gray) obtained by determining the UCL1684- and TRAM34-
senstive currents. The summary of UCL1684 and TRAM34-sensitive currents is depicted in the inset (n=4
each). F, Summary of normalized ATP-stimulated I-V plots taken from the end of the initial peak response
(plot 1) and during the peak of the sustained phase of the response (plot 2). A representative time course of
the ATP-stimulated current measured at +40 mV is shown in the inset (n=4 each). Summary data presented
as meanSEM. IKCa channels indicate intermediate conductance Ca2+-activated K+ channels; SKCa
channels, small conductance Ca2+-activated K+ channels.
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completely as with Pyr3 inhibition. NS309 (SK/IKCa activator)
was applied to demonstrate similar potential for hyperpolar-
ization through KCa channel activation in the ECs from TRPC3
KO mice. The effect of Pyr3 was additionally evaluated in the
presence of TRAM34 to isolate the role of TRPC3 in SKCa
current activation (Figure 7B). Note that combined applica-
tion of Pyr3 and TRAM34 nearly abolished the ATP-stimulated
current, demonstrating significant TRPC3-dependence of
SKCa current activation. The requirement of TRPC3 in SKCa
channel activation is further supported by the virtually
identical effect of TRPC3 or SKCa channel inhibition on
ATP-stimulated hyperpolarization and the time course of
current activation (compare with Figure 6B and 6D).
Together, these results demonstrate a critical role of TRPC3
in the regulation of SKCa channel activation and EC
hyperpolarization.
Evidence of TRPC3 Channel Trafficking in SKCa
Channel Activation
In light of the latency between receptor stimulation and SKCa
channel activation, we investigated the possibility that
channel trafficking was involved in this component of EC
hyperpolarization. Figure 8 demonstrates the effect of 2
successive ATP applications on EC current activation. In these
experiments, we isolated the SKCa current by maintaining
TRAM34 throughout. Figure 8A depicts a representative
experiment in which ATP was added twice to the same EC
preparation with a 10-minute washout between exposures. To
ensure uniform delivery of ATP, the recording chamber was
rapidly flushed with the ATP-containing solution. With the first
application of ATP, SKCa current increased gradually to

































Figure 7. Role of TRPC3 in ATP-mediated hyperpolarization and SKCa channel activation of freshly
isolated cerebral ECs. A, Summary of ATP-mediated (100 lmol/L) hyperpolarization responses in ECs
treated with vehicle (n=7) or TRPC3 blocker (Pyr3, 1 lmol/L; n=5). B, Summary of ATP-stimulated K+
current at +40 mV obtained from sequential I-V sweeps. Measurements were performed following no
treatment (cont; n=7), TRPC3 blocker (Pyr3; n=3), and TRPC3 blocker plus IKCa blocker (Pyr3+TRAM34;
n=4). C, Summary of ATP-mediated (100 lmol/L) hyperpolarization responses in freshly isolated ECs from
WT (n=8) and TRPC3 KO mice (n=5). D, Summary of hyperpolarization response to SK/IKCa channel
activator (NS309, 10 lmol/L) in ECs isolated from WT (n=3) and TRPC3 KO mice (n=7). All data presented
as meanSEM. IKCa channels indicate intermediate conductance Ca2+-activated K+ channels; SKCa
channels, small conductance Ca2+-activated K+ channels; KO, knockout; TRPC3, transient receptor potential
C3; WT, wild type.
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to ATP a second time, SKCa current reached maximum
activation almost immediately. SKCa current (normalized to
maximum current) after first and second ATP responses is
summarized in Figure 8B. These data demonstrate a clear
effect of prior receptor stimulation on the rate of SKCa
channel activation and suggest a possible role of channel
trafficking in response to ATP stimulation.
To explain the differences in rate of SKCa current activation,
we first considered the possibility that SKCa channels were
trafficked to the PM after ATP stimulation. Precedent for rapid
trafficking of SK3 channels has recently been provided in
mouse aorta ECs after receptor activation.42 Apamin is an
irreversible blocker of SKCa channels and has been used in the
demonstration of SKCa channel trafficking to the PM.
42 In this
method, brief exposure of apamin is used to irreversibly inhibit
surface expressed SKCa channels. Return of SKCa current
(measured by patch clamp) would thus be reflective of newSKCa
channels trafficked to the PM. Figure 9 (left panel) demon-
strates a representative experiment in which apamin was
applied for 2 minutes and then washed out (n=3). Subsequent
ATP application elicited a very transient whole-cell current,
similar to the response obtained in the continued presence of
SKCa channel blockers (Figure 6D). When the experiment was
performed in the presence of TRAM34 to isolate the SKCa
























Figure 8. Time course of ATP-stimulated SKCa current activa-
tion in freshly isolated ECs after first and second ATP application
(left). Representative ATP-stimulated SKCa current at +40 mV
after first ATP application (top) and after second ATP application
(bottom). TRAM34 (1 lmol/L) was present throughout to isolate
the SKCa current. ATP was washed out for 10 minutes between
first and second exposures (right). Summary of normalized ATP-
stimulated SKCa current for first and second ATP exposures (n=3).
Two-way repeated-measures ANOVA significant interaction
between groups P=0.034. Summary data presented as mean
SEM. SKCa channels indicate small conductance Ca2+-activated
K+ channels.
ATPATP
Figure 9. Evidence against SKCa channel trafficking to the plasma membrane following receptor
stimulation in cerebral ECs. Representative whole-cell current recordings from freshly isolated cerebral ECs
in response to ATP stimulation (100 lmol/L). Apamin (200 nmol/L) was very briefly applied to freshly
isolated ECs (2 minutes) and then washed out before ATP application. (left) Representative recording for
ATP response following apamin pretreatment. The resulting current should consist of IKCa current and any
potential SKCa current from recruited SKCa channels (see illustration). (right) Representative recording for
ATP response following apamin pretreatment plus sustained treatment with TRAM34 (1 lmol/L). The
resulting current should consist only of any potential SKCa current from recruited SKCa channels (see
illustration). Current was measured at +40 mV. The point of ATP application is indicated by the arrows. Brief
exposure to apamin eliminated the sustained current (left) and all SKCa current (right). Traces are
representative of 3 to 5 experiments for each group. IKCa channels indicate intermediate conductance Ca
2+-
activated K+ channels; SKCa channels, small conductance Ca
2+-activated K+ channels.
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up to 20 minutes of recording (n=5). Thus, these findings
strongly argue against trafficking of the SKCa channel in
cerebral ECs over the time course of the delayed SKCa current
response.
Trafficking of TRPC3 channels has also been demonstrated
through insertion and removal of intracellular vesicles.43–48
Given that TRPC3 channels appear to be critical to regulating
SKCa channel activation, we reasoned that trafficking of TRPC3
could account for delayed SKCa channel activation. Pressurized
cerebral arteries and freshly isolated ECs from WT and TRPC3
KO mice were used to demonstrate TRPC3 expression in
endothelium and to confirm specificity of the antibody
(Figure 10 A and 10B). Next, pressurized arteries were treated
with vehicle (control) or ATP (100 lmol/L) for 10 minutes
before fixation and processing for TRPC3 immunofluores-
cence. High magnification (1009 oil) deconvolution imaging
demonstrated a redistribution of TRPC3 immunofluorescence
with ATP stimulation (Figure 10C and 10D). In control arteries,
TRPC3 expression was distributed throughout the ECs, with
only slight accumulation at the PM. After ATP stimulation,
however, TRPC3 accumulated along the PM and was recipro-
cally decreased throughout the cytosolic compartment. This
accumulation was most evident in the PM in the vicinity of the
nucleus. Images are representative of artery preparations from
3 mice in each group. The cytosolic-to-PM redistribution was
even more apparent in 3-dimensional reconstructions created
from planes covering a depth of 2 lm (Figure 10D).
Given that TRPC3 is thought to traffic through vesicular
fusion/removal from the PM, we expected that greater TRPC3
trafficking to the PM should be associated with an increase in
PM surface area. We therefore measured Cm in cerebral ECs
before and after ATP stimulation, as a real-time measurement
of PM surface area. Figure 11 summarizes Cm measurements
in response to ATP. Note that application of ATP produced a
rapid increase in EC Cm of a similar time course as SKCa
current recruitment. When considered with the immunofluo-
rescence data, these findings are consistent with ATP-
stimulated trafficking of TRPC3-containing vesicles to the
PM in the mechanism of SKCa activation.
Discussion
We present the following novel findings regarding the role of
TRPC3 in endothelium-mediated vasodilation in the cerebral
circulation: (1) TRPC3 contributes to EDH-mediated vasodila-
tion of pressurized cerebral artery, (2) TRPC3 contributes to
receptor-mediated Ca2+ regulation in the endothelium intact
cerebral artery, (3) receptor-mediated EC hyperpolarization
is initiated by IKCa channel activation and maintained by
subsequent SKCa channel activation, and (4) rapid recruitment
of TRPC3 to the PM is critical for SKCa channel activation and




























Ca2+-free No ATP ATPD
Figure 10. TRPC3 immunofluorescence demonstrating ATP-
stimulated trafficking of TRPC3 channels to plasma membrane in
EC of intact cerebral artery. A, Immunofluorescence images of en
face preparations of PCA from WT and TRPC3 KO mice acquired
with 609 oil objective. WT and KO mice were bred on a Cx40BAC-
GCaMP2 background to provide GFP expression selectively in the
endothelium. The arteries were fixed while pressurized and then
cut open for direct access to the endothelium. The green
fluorescence reflects EC-specific GFP as well as autofluorescence
of the underlying internal elastic lamina (IEL). The GFP signal
(green) was used to establish the proper focal plane of the thin
endothelial layer for TRPC3 immunofluorescence (red). Nuclei were
stained with DAPI (blue). White scale bar=10 lm. B, TRPC3
immunofluorescence images (1009 oil objective) of freshly
isolated cerebral EC clusters from WT and TRPC3 KO mice (red).
Nuclei were stained with DAPI (blue). White scale bar= 10 lm. C,
Representative TRPC3 immunofluorescence of cerebral endothe-
lium from pressurized arteries treated with saline (Control) or ATP
(100 lmol/L) for 10 minutes. After treatment, pressurized arter-
ies were immediately fixed in the chamber and cut open for TRPC3
immunofluorescence (red). EC were imaged in en face preparations
with 1009 oil objective. Z stack images were acquired at 0.2-lm
intervals for deconvolution. Images shown represent a maximum
projection along the z axis of 5 planes (1 lm thickness). DAPI
nuclei (blue) are shown in the bottom panel, whereas the nuclear
border is indicated by dotted line in the upper panel. White scale
bar = 5 lm. D, Representative 3-dimensional reconstructions of
deconvolved EC TRPC3 immunofluorescence signal (red) from
arteries treated with Ca2+-free buffer, Ca2+-containing buffer (No
ATP), and Ca2+-containing buffer with 100 lmol/L ATP (ATP).
Images represent a 2-lm-thick optical section centered about the
nucleus. DAPI indicates 40,6-Diamidino-z-phenylindole dihy-
drochloride; KO, knockout; PAC, posterior cerebral artery; TRPC3,
transient receptor potential C3; WT, wild type.
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sustained EC hyperpolarization. We propose a new model in
which TRPC3-containing vesicles are inserted into the PM on
receptor stimulation, where the newly inserted TRPC3 then
contributes to SKCa channel activation, EC hyperpolarization,
and enhanced EDH-mediated vasodilation (see Figure 12).
TRPC3 Contributes to EDH-Mediated Vasodilation
in Cerebral Artery
In the present study, we specifically tested the role of TRPC3 in
EDH-mediated response to ATP, a potent physiological vaso-
dilator in the cerebral circulation. It has been shown that EDH-
mediated vasodilation plays a major role in controlling blood
flow in isolated cerebral arteries and arterioles.40,49 Addition-
ally, recent laser Doppler studies suggest an in vivo role of
EDH-mediated control of cerebral blood flow in mice.13 Our
data presented here demonstrate for the first time that the
EDH-dependent mechanism in mouse cerebral artery critically
involves TRPC3 for fully functional vasodilation to ATP.
To date, only a few prior studies have linked TRPC3 in the
mechanism of endothelium-dependent vasodilation, though no
prior study has demonstrated such a role in the cerebral
circulation. In one of the earliest studies linking TRPC3 to
endothelial regulation of vasorelaxation, Liu et al20 used
antisense oligos delivered in vivo to knock down endothelial
expression of TRPC3 in rat mesenteric arteries. They subse-
quently demonstrated attenuation of flow-induced vasodilation
and bradykinin-induced vasorelaxation in arteries of antisense-
treated rats. Interestingly, vasorelaxation to histamine, ATP,
and cyclopiazonic acid was not affected by TRPC3 knockdown
in this preparation. More recently, an isoform-specific phar-
macological blocker of TRPC3 (Pyr3) was developed that has
enabled acute pharmacological evaluation of TRPC3 channel
function.50 This blocker has since been used to demonstrate
the involvement of TRPC3 in bradykinin-induced relaxation in
isolated porcine coronary arteries,21 as well as acetylcholine/
carbacholine–induced relaxation in human mammary artery,51
mouse mesenteric artery,8 and mouse aorta.32
TRPC3 Contributes to Sustained Endothelial Ca2+
Influx After Receptor Stimulation
We have demonstrated in the present study that decreased
arterial relaxation to ATP after TRPC3 KO or Pyr3 pretreat-
ment correlates with an attenuated endothelial Ca2+ response
measured in intact pressurized arteries. Although Ca2+ influx
through TRPC3 channels has been previously demonstrated in
numerous cell types (see reviews19, 52), the specific role of
TRPC3 in endothelial Ca2+ regulation is not fully elucidated.
Our data show that TRPC3 (evaluated by Pyr3 or TRPC3 KO)
primarily affects the duration of the cerebral EC Ca2+
response to ATP. Furthermore, Mn2+-quenching experiments
show relatively long-lasting Pyr3-sensitive cation influx after
ATP stimulation. Additionally, these data demonstrated no
apparent effect of Pyr3 on basal Ca2+ influx, thus suggesting
little contribution of constituitively active TRPC3 residing in
the PM before receptor stimulation. Such a role of TRPC3 in
producing sustained Ca2+ influx after receptor stimulation is
consistent with our model in which we propose a requirement
for TRPC3 trafficking to provide the source of Ca2+ for SKCa
channel activation and EC hyperpolarization.
TRPC3 Is Required for Receptor-Mediated SKCa
Channel Activation
Given our demonstration of TRPC3 in EDH-mediated vasodi-
lation and EC Ca2+ regulation in this artery, we examined the
potential link between TRPC3 activity and SK/IKCa channel
activation. Experiments with a TRPC3 blocker (Pyr3) and with
ECs from TRPC3 KO mice demonstrated a clear role for TRPC3
in regulating SKCa channel activity. Receptor-mediated hyper-
polarization was virtually identically affected by TRPC3 block-
ade/ablation as with SKCa channel inhibition—namely, there
















Figure 11. ATP-stimulated increase in plasma membrane sur-
face area of freshly isolated cerebral ECs measured by whole-cell
capacitance. Real-time measurement of EC whole-cell capaci-
tance (Cm) was used to evaluate the effect of ATP stimulation on
plasma membrane surface area. The tested model predicts
vesicular fusion with the plasma membrane and thus increased
membrane surface area/measured Cm following receptor stimu-
lation (see illustration). The data summarizes mean Cm following
ATP stimulation (100 lmol/L) in freshly isolated cerebral ECs.
The gap in the trace reflects removal of the artifactual data points
immediately after bath solution change. Baseline Cm was
normalized to unity. Data are presented as meanSEM (n=3 EC
clusters from 3 separate mice). The inset is a representative
individual recording of Cm in response to ATP application. TRPC3
indicates transient receptor potential C3.
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significant attenuation of the sustained component (compare
Figures 6B and 7A). The effect on TRPC3 blockade/ablation
similarly mimicked the effect of SKCa inhibition on K
+ current
activation (compare Figures 6D and 7B). These studies
suggested a clear requirement of functional TRPC3 channel
for SKCa channel activation. We have recently reported a role
for TRPC3 in SKCa and IKCa channel activation in rat mesenteric
artery,8 indicating that a role for TRPC3 in regulating Ca2+-
activated K channels is not unique to the cerebral circulation.
However, unlike our findings in mesenteric artery, we found no
evidence for significant TRPC3-dependent regulation of IKCa
channels in the cerebral circulation.
Receptor-Mediated Activation of ECs Leads to
Biphasic Activation of IKCa and SKCa Channels
EDH-mediated vasodilation in peripheral circulations is often
































Figure 12. Proposed role of endothelial TRPC3 trafficking in SKCa channel activation to produce
sustained EC hyperpolarization and EDH-mediated vasodilation. Endothelial receptor stimulation leads to EC
hyperpolarization (Vm) through 2 phases. In the early phase, Ca2+ released from IP3 receptors (IP3R) leads
to IKCa channel activation and the initial EC hyperpolarization. Ca
2+-dependent trafficking of TRPC3-
containing vesicles to the plasma membrane (PM) is also initiated in this phase. The late phase begins on
vesicular fusion with the PM and TRPC3 channel insertion. TRPC3 channel activation (PLC-derived DAG or
constitutively active) promotes sustained Ca2+ influx and SKCa channel activation. This late phase is
characterized by the loss of IKCa-dependent EC hyperpolarization and the gain of SKCa-dependent EC
hyperpolarization. EC hyperpolarization is transferred to the adjacent smooth muscle at regions of
heterocellular contact through the internal elastic lamina (IEL) via myoendothelial gap junctions (MEGJ).
Smooth muscle hyperpolarization leads to subsequent vasodilation and increased blood flow. EDH indicates
endothelium-dependent hyperpolarization; IKCa channels, intermediate conductance Ca
2+-activated K+
channels; PLC, phospholipase C; DAG, diacylglycerol; VSMC, vascular smooth muscle cell; SKCa channels,
small conductance Ca2+-activated K+ channels.
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channels.53 For instance, combined inhibition of SKCa and IKCa
channels is required to block EDH-mediated vasodilation,
whereas inhibition of either channel alone is insufficient to
block the response.54 In the cerebral circulation, however,
inhibition of IKCa channels alone has been shown to substan-
tially blunt or eliminate EDH-mediated vasodilation.25,55,56
While SKCa channels do not appear to be critical for initiating
EDH-mediated vasodilation, the full role of SKCa channels in
this mechanism is yet to be resolved. Our present study
corroborates the critical role of IKCa channels in providing the
initial EC hyperpolarization that is required for EDH-mediated
vasodilation; however, it also establishes an important role for
SKCa channels in sustaining the hyperpolarization. Our claim
of 2 temporal components of EC hyperpolarization is
supported by our measurements of hyperpolarization and K+
current activation in the presence of specific blockers to
isolate SKCa and IKCa effects. In these studies, we found that
IKCa channel activation and IKCa channel–mediated hyperpo-
larization occurred immediately after receptor stimulation but
began rapidly decaying within the first minute (see Figure 6B
and 6D). SKCa channel activation occurred more gradually but
was sustained for several minutes (see Figure 8). The 2
distinct currents were also evident in the current-voltage plots
recorded at early and later times after receptor stimulation
(see Figure 6F). In this experiment, current-voltage plots
appeared to be initially dominated by IKCa-like currents before
shifting to predominantly SKCa-like currents during the
sustained phase. Together, these findings demonstrate a
time-dependent transition from IKCa to SKCa channel depen-
dence. We propose that the initial EC hyperpolarization
requires IKCa channel activation, while sustaining that hyper-
polarization requires SKCa channel activation through pro-
longed Ca2+ influx via TRPC3 channels.
Role of Vesicular Trafficking in TRPC3-Dependent
Activation of SKCa Channels
The delayed onset of the SKCa current could have multiple
explanations; however, in the context of our studies, 2
possible scenarios seemed initially plausible. In the first
scenario, SKCa channels could be trafficked to the PM in
response to receptor stimulation, where they would then be
activated by TRPC3 channels already present in the mem-
brane. Precedent for SKCa channel trafficking has recently
been established for SK3 channels in mouse aortic ECs.42 In
the second scenario, TRPC3 channels could be trafficked to
the PM where they would then contribute to SKCa channel
activation. There is considerable recent evidence for TRPC3
channel trafficking in a variety of neuronal cell and EC
preparations,43,44,47,48,57 as well as one study suggesting
TRPC3 trafficking in cultured porcine coronary ECs.21 We
discuss the evidence for each of these scenarios further
next.
SKCa channel trafficking
Lin et al reported trafficking of SKCa channels (presumed SK3)
in mouse aorta ECs.42 In that study, they used brief apamin
exposure to irreversibly inhibit surface SKCa channels and
then monitored for recovery of SKCa current on washout.
Within minutes of washout, they found rapid recovery of SKCa
current that was abolished by disruption of Ca2+-dependent
vesicular trafficking. Our data in cerebral ECs, however, were
not consistent with similar SKCa trafficking. In particular, after
brief application of apamin, the sustained component (after
ATP challenge) remained absent during the apamin washout
period. In addition, cells treated with TRAM34 (to isolate the
SKCa current) failed to produce any current in response to ATP
during the apamin washout period for up to 20 minutes (see
Figure 9). From our studies in which apamin or UCL1684 was
not included, we found that the SKCa current otherwise
appeared in less than 1 minute and peaked within 5 minutes.
In short, trafficking of SKCa does not appear to account for the
gradually increasing SKCa current after initial receptor stim-
ulation or the immediately responsive SKCa current after prior
ATP stimulation.
TRPC3 channel trafficking
Recent evidence indicates that TRPC3 channels can be
actively trafficked to and from the PM in a variety of cell
types43,44,47,48,57 through distinct constitutive and receptor-
mediated trafficking pathways.47 TRPC3 has been localized
to vesicles and associates with several key proteins
involved in SNARE-mediated vesicular trafficking.48,57,58
The SNARE proteins and Ca2+-sensitive SNARE associating
proteins provide the necessary components for docking of
vesicles at the subplasmalemmal surface and ultimate
vesicular fusion with the PM (exocytosis).59,60 In the
present study, we demonstrated consolidation of TRPC3 at
the EC PM of pressurized arteries after ATP stimulation,
consistent with increased forward trafficking of TRPC3-
containing vesicles to the PM (Figure 10). We also demon-
strated rapid increase in cell capacitance (correlates with
PM surface area) following ATP stimulation of freshly
isolated ECs, consistent with the fusion of exocytotic
vesicles with the PM (see Figure 11). The time course of
this increase in PM surface area correlated very well with
the corresponding increase in SKCa-mediated current and EC
hyperpolarization. When the evidence is considered as a
whole, it appears that receptor-mediated trafficking of
TRPC3 channels occurs and contributes to SKCa channel
regulation in cerebral endothelium.
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Limitations
In the present studies, we used a combination of global TRPC3
KO mice and Pyr3 to evaluate the role of endothelial TRPC3 in
the regulation of EC calcium, EC SK/IKCa channels, and
ultimately vasodilation of cerebral artery. Use of global TRPC3
KO mice is appropriate for studies involving isolated ECs;
however, these mice are not ideal for pressurized artery
experiments due to the additional loss of TRPC3 expression in
vascular smooth muscle, perivascular nerves, etc. For the
pressurized artery experiments, we instead used Pyr3 at a
concentration that we found to produce TRPC3-specific inhibi-
tion of endothelial Ca2+ responses (Figure 3C) and that we
previously found to target endothelial function over smooth
muscle function in mesenteric arteries. Nevertheless, we
cannot fully exclude nonendothelial effects of Pyr3 in the
attenuation of ATP-mediated vasodilation. For a more specific
determination of the role of endothelial TRPC3 channels in
intact arteries and in vivo blood flow, we are currently
developing EC-specific TRPC3 KO mice.
With regard to the proposed mechanism of TRPC3
regulation of SKCa channels, we have provided multiple pieces
of evidence for the functional interaction of these channels.
However, we have not directly demonstrated a close physical
association between these 2 ion channels. Our proposed
trafficking model would be strengthened by future demon-
stration of physical association and disassociation of these
channels in a P2Y2 receptor–dependent fashion. We have also
assumed that TRPC3 channels are shuttled to and from the
PM through forward and reverse vesicular trafficking as in
other cell types. Although defining the exact mechanism of
TRPC3 trafficking is not critical to our overall model of TRPC3-
dependent regulation of SKCa channel activity, further study
into receptor-mediated TRPC3 trafficking in cerebrovascular
endothelium could demonstrate additional targets for SKCa
channel regulation and the ultimate regulation of cerebrovas-
cular tone.
Summary
We demonstrate that TRPC3 channels are functionally
expressed in cerebral ECs and play a critical role in regulating
Ca2+ influx and ATP-induced hyperpolarization. TRPC3 channel
activation is essential for the SKCa channel–dependent EC
hyperpolarization that develops subsequent to the initial IKCa
channel–mediated hyperpolarization. Furthermore, TRPC3-
mediated regulation of SKCa channels appears to involve
trafficking of TRPC3 channels to the PM, where they then
provide the source of Ca2+ influx for SKCa channel activation.
Ultimately, TRPC3-dependent regulation of SKCa channel
activation appears to be an important component of sustained
EDH-mediated vasodilation in cerebral arteries.
Sources of Funding
This study was supported by National Institutes of Health
(NIH), National Heart, Lung, and Blood Institute grant R01
HL088435 to Dr Marrelli and by the Intramural Research Pro-




1. Pan Z, Yang H, Reinach PS. Transient receptor potential (TRP) gene superfamily
encoding cation channels. Hum Genomics. 2011;5:108–116.
2. Wu LJ, Sweet TB, Clapham DE. International union of basic and clinical
pharmacology. LXXVI. current progress in the mammalian TRP ion channel
family. Pharmacol Rev. 2010;62:381–404.
3. Marrelli SP, O’neil RG, Brown RC, Bryan RM Jr. PLA2 and TRPV4 channels
regulate endothelial calcium in cerebral arteries. Am J Physiol Heart Circ
Physiol. 2007;292:H1390–H1397.
4. Brayden JE, Earley S, Nelson MT, Reading S. Transient receptor potential (TRP)
channels, vascular tone and autoregulation of cerebral blood flow. Clin Exp
Pharmacol Physiol. 2008;35:1116–1120.
5. Zhang DX, Gutterman DD. Transient receptor potential channel activation and
endothelium-dependent dilation in the systemic circulation. J Cardiovasc
Pharmacol. 2011;57:133–139.
6. Earley S, Gonzales AL, Crnich R. Endothelium-dependent cerebral artery
dilation mediated by TRPA1 and Ca2+-activated K+ channels. Circ Res.
2009;104:987–994.
7. Earley S. Endothelium-dependent cerebral artery dilation mediated by
transient receptor potential and ca(2+)-activated K(+) channels. J Cardiovasc
Pharmacol. 2011;57:148–153.
8. Senadheera S, Kim Y, Grayson TH, Toemoe S, Kochukov MY, Abramowitz J,
Housley GD, Bertrand RL, Chadha PS, Bertrand PP, Murphy TV, Tare M,
Birnbaumer L, Marrelli SP, Sandow SL. Transient receptor potential
canonical type 3 channels facilitate endothelium-derived hyperpolariza-
tion-mediated resistance artery vasodilator activity. Cardiovasc Res. 2012;
95:439–447.
9. Sonkusare SK, Bonev AD, Ledoux J, Liedtke W, Kotlikoff MI, Heppner TJ, Hill-
Eubanks DC, Nelson MT. Elementary Ca2+ signals through endothelial TRPV4
channels regulate vascular function. Science. 2012;336:597–601.
10. Dora KA, Gallagher NT, McNeish A, Garland CJ. Modulation of endothelial cell
KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling
in mesenteric resistance arteries. Circ Res. 2008;102:1247–1255.
11. Chadha PS, Liu L, Rikard-Bell M, Senadheera S, Howitt L, Bertrand RL, Grayson
TH, Murphy TV, Sandow SL. Endothelium-dependent vasodilation in human
mesenteric artery is primarily mediated by myoendothelial gap junctions
intermediate conductance calcium-activated K+ channel and nitric oxide.
J Pharmacol Exp Ther. 2011;336:701–708.
12. Behringer EJ, Segal SS. Tuning electrical conduction along endothelial tubes of
resistance arteries through ca(2+)-activated K(+) channels. Circ Res.
2012;110:1311–1321.
13. Hannah RM, Dunn KM, Bonev AD, Nelson MT. Endothelial SK(ca) and IK(ca)
channels regulate brain parenchymal arteriolar diameter and cortical cerebral
blood flow. J Cereb Blood Flow Metab. 2011;31:1175–1186.
14. Hasenau AL, Nielsen G, Morisseau C, Hammock BD, Wulff H, Kohler R.
Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20,
activators of small- and intermediate-conductance Ca2+ -activated K+
-channels. Acta Physiol (Oxf). 2011;203:117–126.
15. Dalsgaard T, Kroigaard C, Bek T, Simonsen U. Role of calcium-activated
potassium channels with small conductance in bradykinin-induced vasodila-
tion of porcine retinal arterioles. Invest Ophthalmol Vis Sci. 2009;50:3819–
3825.
16. Kurian MM, Berwick ZC, Tune JD. Contribution of IKCa channels to the control
of coronary blood flow. Exp Biol Med (Maywood). 2011;236:621–627.
17. Mishra RC, Belke D, Wulff H, Braun AP. SKA-31, a novel activator of SK(ca) and
IK(ca) channels, increases coronary flow in male and female rat hearts.
Cardiovasc Res. 2013;97:339–348.
DOI: 10.1161/JAHA.114.000913 Journal of the American Heart Association 16















 at NIH Library on November 10, 2014http://jaha.ahajournals.org/Downloaded from 
18. Albert AP. Gating mechanisms of canonical transient receptor potential
channel proteins: role of phosphoinositols and diacylglycerol. Adv Exp Med
Biol. 2011;704:391–411.
19. Smedlund K, Bah M, Vazquez G. On the role of endothelial TRPC3 channels in
endothelial dysfunction and cardiovascular disease. Cardiovasc Hematol
Agents Med Chem. 2012;10:265–274.
20. Liu CL, Huang Y, Ngai CY, Leung YK, Yao XQ. TRPC3 is involved in flow- and
bradykinin-induced vasodilation in rat small mesenteric arteries. Acta
Pharmacol Sin. 2006;27:981–990.
21. Huang JH, He GW, Xue HM, Yao XQ, Liu XC, Underwood MJ, Yang Q. TRPC3
channel contributes to nitric oxide release: significance during normoxia and
hypoxia-reoxygenation. Cardiovasc Res. 2011;91:472–482.
22. Hartmann J, Dragicevic E, Adelsberger H, Henning HA, Sumser M, Abramowitz
J, Blum R, Dietrich A, Freichel M, Flockerzi V, Birnbaumer L, Konnerth A. TRPC3
channels are required for synaptic transmission and motor coordination.
Neuron. 2008;59:392–398.
23. Tallini YN, Brekke JF, Shui B, Doran R, Hwang SM, Nakai J, Salama G, Segal SS,
Kotlikoff MI. Propagated endothelial Ca2+ waves and arteriolar dilation in vivo:
measurements in Cx40BAC GCaMP2 transgenic mice. Circ Res. 2007;101:
1300–1309.
24. Homolya L, Watt WC, Lazarowski ER, Koller BH, Boucher RC. Nucleotide-
regulated calcium signaling in lung fibroblasts and epithelial cells from normal
and P2Y(2) receptor (-/-) mice. J Biol Chem. 1999;274:26454–26460.
25. Marrelli SP, Eckmann MS, Hunte MS. Role of endothelial intermediate
conductance KCa channels in cerebral EDHF-mediated dilations. Am J Physiol
Heart Circ Physiol. 2003;285:H1590–H1599.
26. Golding EM, Ferens DM, Marrelli SP. Altered calcium dynamics do not
account for attenuation of endothelium-derived hyperpolarizing factor-
mediated dilations in the female middle cerebral artery. Stroke. 2002;33:
2972–2977.
27. Marrelli SP. Altered endothelial Ca2+ regulation after ischemia/reperfusion
produces potentiated endothelium-derived hyperpolarizing factor-mediated
dilations. Stroke. 2002;33:2285–2291.
28. Marrelli SP. Mechanisms of endothelial P2Y(1)- and P2Y(2)-mediated vasodi-
latation involve differential [Ca2+]i responses. Am J Physiol Heart Circ Physiol.
2001;281:H1759–H1766.
29. Marrelli SP. Selective measurement of endothelial or smooth muscle [ca(2+)](i)
in pressurized/perfused cerebral arteries with fura-2. J Neurosci Methods.
2000;97:145–155.
30. Marrelli SP, Khorovets A, Johnson TD, Childres WF, Bryan RM Jr. P2
purinoceptor-mediated dilations in the rat middle cerebral artery after
ischemia-reperfusion. Am J Physiol. 1999;276:H33–H41.
31. Suh SH, Vennekens R, Manolopoulos VG, Freichel M, Schweig U, Prenen J,
Flockerzi V, Droogmans G, Nilius B. Characterisation of explanted endothelial
cells from mouse aorta: electrophysiology and Ca2+ signalling. Pflugers Arch.
1999;438:612–620.
32. Kochukov MY, Balasubramanian A, Noel RC, Marrelli SP. Role of TRPC1 and
TRPC3 channels in contraction and relaxation of mouse thoracic aorta. J Vasc
Res. 2013;50:11–20.
33. Lindau M, Neher E. Patch-clamp techniques for time-resolved capacitance
measurements in single cells. Pflugers Arch. 1988;411:137–146.
34. Namiranian K, Lloyd EE, Crossland RF, Marrelli SP, Taffet GE, Reddy AK,
Hartley CJ, Bryan RM Jr. Cerebrovascular responses in mice deficient in the
potassium channel, TREK-1. Am J Physiol Regul Integr Comp Physiol. 2010;299:
R461–R469.
35. Tallini YN, Ohkura M, Choi BR, Ji G, Imoto K, Doran R, Lee J, Plan P, Wilson J,
Xin HB, Sanbe A, Gulick J, Mathai J, Robbins J, Salama G, Nakai J, Kotlikoff MI.
Imaging cellular signals in the heart in vivo: cardiac expression of the
high-signal Ca2+ indicator GCaMP2. Proc Natl Acad Sci USA. 2006;103:4753–
4758.
36. Ledoux J, Taylor MS, Bonev AD, Hannah RM, Solodushko V, Shui B, Tallini Y,
Kotlikoff MI, Nelson MT. Functional architecture of inositol 1,4,5-trisphosphate
signaling in restricted spaces of myoendothelial projections. Proc Natl Acad
Sci USA. 2008;105:9627–9632.
37. Wang HR, Wu M, Yu H, Long S, Stevens A, Engers DW, Sackin H, Daniels JS,
Dawson ES, Hopkins CR, Lindsley CW, Li M, McManus OB. Selective inhibition
of the K(ir)2 family of inward rectifier potassium channels by a small molecule
probe: the discovery, SAR, and pharmacological characterization of ML133.
ACS Chem Biol. 2011;6:845–856.
38. Millar ID, Wang S, Brown PD, Barrand MA, Hladky SB. Kv1 and Kir2 potassium
channels are expressed in rat brain endothelial cells. Pflugers Arch.
2008;456:379–391.
39. Horiuchi T, Dietrich HH, Hongo K, Dacey RG Jr. Comparison of P2 receptor
subtypes producing dilation in rat intracerebral arterioles. Stroke. 2003;
34:1473–1478.
40. You J, Johnson TD, Marrelli SP, Bryan RM Jr. Functional heterogeneity of
endothelial P2 purinoceptors in the cerebrovascular tree of the rat. Am J
Physiol. 1999;277:H893–H900.
41. Ledoux J, Bonev AD, Nelson MT. Ca2+-activated K+ channels in murine
endothelial cells: block by intracellular calcium and magnesium. J Gen Physiol.
2008;131:125–135.
42. Lin MT, Adelman JP, Maylie J. Modulation of endothelial SK3 channel activity
by ca(2)+dependent caveolar trafficking. Am J Physiol Cell Physiol. 2012;303:
C318–C327.
43. Fauconnier J, Lanner JT, Sultan A, Zhang SJ, Katz A, Bruton JD, Westerblad H.
Insulin potentiates TRPC3-mediated cation currents in normal but not in
insulin-resistant mouse cardiomyocytes. Cardiovasc Res. 2007;73:376–385.
44. Goel M, Sinkins WG, Zuo CD, Hopfer U, Schilling WP. Vasopressin-induced
membrane trafficking of TRPC3 and AQP2 channels in cells of the rat renal
collecting duct. Am J Physiol Renal Physiol. 2007;293:F1476–F1488.
45. Goel M, Zuo CD, Schilling WP. Role of cAMP/PKA signaling cascade in
vasopressin-induced trafficking of TRPC3 channels in principal cells of the
collecting duct. Am J Physiol Renal Physiol. 2010;298:F988–F996.
46. Kim EY, Alvarez-Baron CP, Dryer SE. Canonical transient receptor potential
channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated
K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured
podocytes. Mol Pharmacol. 2009;75:466–477.
47. Smyth JT, Lemonnier L, Vazquez G, Bird GS, Putney JW Jr. Dissociation of
regulated trafficking of TRPC3 channels to the plasma membrane from their
activation by phospholipase C. J Biol Chem. 2006;281:11712–11720.
48. van Rossum DB, Oberdick D, Rbaibi Y, Bhardwaj G, Barrow RK, Nikolaidis N,
Snyder SH, Kiselyov K, Patterson RL. TRP_2, a lipid/trafficking domain that
mediates diacylglycerol-induced vesicle fusion. J Biol Chem. 2008;283:34384–
34392.
49. Cipolla MJ, Smith J, Kohlmeyer MM, Godfrey JA. SKCa and IKCa channels,
myogenic tone, and vasodilator responses in middle cerebral arteries and
parenchymal arterioles: effect of ischemia and reperfusion. Stroke.
2009;40:1451–1457.
50. Kiyonaka S, Kato K, Nishida M, Mio K, Numaga T, Sawaguchi Y, Yoshida T,
Wakamori M, Mori E, Numata T, Ishii M, Takemoto H, Ojida A, Watanabe K,
Uemura A, Kurose H, Morii T, Kobayashi T, Sato Y, Sato C, Hamachi I, Mori Y.
Selective and direct inhibition of TRPC3 channels underlies biological activities
of a pyrazole compound. Proc Natl Acad Sci USA. 2009;106:5400–5405.
51. Gao G, Bai XY, Xuan C, Liu XC, Jing WB, Novakovic A, Yang Q, He GW. Role of
TRPC3 channel in human internal mammary artery. Arch Med Res.
2012;43:431–437.
52. Birnbaumer L. The TRPC class of ion channels: a critical review of their roles in
slow, sustained increases in intracellular ca(2+) concentrations. Annu Rev
Pharmacol Toxicol. 2009;49:395–426.
53. de Wit C, Griffith TM. Connexins and gap junctions in the EDHF phenomenon
and conducted vasomotor responses. Pflugers Arch. 2010;459:897–914.
54. Zygmunt PM, Hogestatt ED. Role of potassium channels in endothelium-
dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br J
Pharmacol. 1996;117:1600–1606.
55. Dong H, Jiang Y, Cole WC, Triggle CR. Comparison of the pharmacological
properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and
mesenteric resistance vessels. Br J Pharmacol. 2000;130:1983–1991.
56. McNeish AJ, Sandow SL, Neylon CB, Chen MX, Dora KA, Garland CJ. Evidence
for involvement of both IKCa and SKCa channels in hyperpolarizing responses
of the rat middle cerebral artery. Stroke. 2006;37:1277–1282.
57. Singh BB, Lockwich TP, Bandyopadhyay BC, Liu X, Bollimuntha S, Brazer SC,
Combs C, Das S, Leenders AG, Sheng ZH, Knepper MA, Ambudkar SV,
Ambudkar IS. VAMP2-dependent exocytosis regulates plasma membrane
insertion of TRPC3 channels and contributes to agonist-stimulated Ca2+
influx. Mol Cell. 2004;15:635–646.
58. Lockwich T, Pant J, Makusky A, Jankowska-Stephens E, Kowalak JA, Markey
SP, Ambudkar IS. Analysis of TRPC3-interacting proteins by tandem mass
spectrometry. J Proteome Res. 2008;7:979–989.
59. Di Giovanni J, Iborra C, Maulet Y, Leveque C, El Far O, Seagar M. Calcium-
dependent regulation of SNARE-mediated membrane fusion by calmodulin.
J Biol Chem. 2010;285:23665–23675.
60. Jahn R, Fasshauer D. Molecular machines governing exocytosis of synaptic
vesicles. Nature. 2012;490:201–207.
DOI: 10.1161/JAHA.114.000913 Journal of the American Heart Association 17















 at NIH Library on November 10, 2014http://jaha.ahajournals.org/Downloaded from 
